Sound waves get Alzheimer’s drug past brain barrier, small study shows
Scientists in an MRI control area plan a focused ultrasound treatment at West Virginia University’s Rockefeller Neuroscience Institute. (Victor Finomore/WVU Rockefeller Neuroscience Institute/AP) In...
View ArticleStudies on negative impacts of sleep deprivation continue to sleep on Blacks
Black people know intrinsically about the myriad of life areas negatively impacted by the fact that the myth of white supremacy is baked into the foundations of all American institutions. But one area...
View ArticleNew Alzheimer’s drugs bring hope. But not equally for all patients.
The medications have not been widely tested in Black people with the disease, underscoring stark — and persistent — disparities Robert Williford, 67, receives a dose of Leqembi at Abington Neurological...
View ArticleBiogen terminates phase 4 efficacy study of aducanumab
Jessica Rinaldi/The Boston Globe Biogen, the maker of aducanumab has announced that it will terminate the Phase 4 trial required by the FDA for aducanumab, the monoclonal antibody against beta amyloid...
View ArticleIs Preclinical Alzheimer’s Disease a Business Product?
Amyloid PET scan The LA Times recently published a fairly negative appraisal of the construct of preclinical Alzheimer’s disease (AD). The article described the recent effort by an international...
View ArticleAhmad Sajjadi interviewed on NBC Los Angeles
Ahmad Sajjadi, MD, PhD, a UCI Neurologist and UCI MIND faculty member was interviewed live on NBC Los Angeles about the recent announcement that talk show host Wendy Williams has been diagnosed with...
View ArticleMIND Matters | Quarterly Newsletter | Winter 2024
Message from the Director Dear Friends of UCI MIND, Happy New Year! We hope that 2024 is off to a positive start for you. As we embark upon a new year, UCI MIND and the field of Alzheimer’s disease...
View ArticleFDA delays decision on donanemab
The FDA today announced that it will convene an advisory panel to review the data submitted to support potential approval of donanemab, a monoclonal antibody against the beta amyloid protein that...
View ArticleArticle 0
UCI MIND faculty member and UCI Neurologist, Ahmad Sajjadi, MD, PhD, awarded UCI Institute for Precision Health Pilot Award. Dr. Sajjadi will work with Tianchen Qian, PhD, a REC trainee and assistant...
View ArticleDr. Ahmad Sajjadi comments on the donanemab decision
Ahmad Sajjadi, MD, PhD, UCI Neurologist and UCI MIND faculty member, was quoted in Healthline regarding the recent announcement by FDA to delay the decision to approve Eli Lilly’s amyloid targeting...
View ArticleDr. Craig Stark takes UCI’s women’s health research to new heights with the...
As we celebrate Women’s History Month this March, we also find ourselves at a historic moment in scientific inquiry for women’s health research. Today, nearly two-thirds of Americans with Alzheimer’s...
View ArticleUCI MIND faculty find that social enrichment is good for the brains of aging...
Jessica Noche, PhD, a postdoctoral scholar and REMIND co-chair recently published an article in the Journal of Neuroscience with UCI MIND faculty, Craig Stark, PhD, and Elizabeth Head, PhD, on the...
View ArticleFrom data to decision-making: the role of machine learning and digital twins...
For patients experiencing cognitive decline due to Alzheimer’s Disease (AD), choosing the most appropriate treatment course at the right time is of great importance. A key element to these decisions is...
View ArticleDr. Liz Head Named Mentor of the Year by UCI SOM
The UC Irvine School of Medicine recognized the 2024 best mentors and Elizabeth Head, PhD, Professor and Vice Chair of Research in the Department of Pathology and Laboratory Medicine was awarded the...
View ArticleDr. Daniel Gillen Named AAAS Fellow
Daniel Gillen, PhD, Chancellor’s Professor and Chair of Statistics and the leader for the ADRC Data Management and Statistics Core was recently named a fellow of the American Association for the...
View Article
More Pages to Explore .....